CUVRIOR
NDC 81802-001, TRIENTINE TETRAHYDROCHLORIDE, tablet, film coated, from Orphalan SA.
- Product NDC
- 81802-001
- Status
- Listed
- Labeler
- Orphalan SA
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215760
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81802-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRIENTINE TETRAHYDROCHLORIDE300 mg/1
Pharmacologic classes
Copper Chelating Activity [MoA]; Copper Chelator [EPC]; Metal Chelating Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81802-001-72 | 81802000172 | 9 CARTON in 1 CARTON (81802-001-72) / 1 BLISTER PACK in 1 CARTON (81802-001-08) / 8 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f73feeae-62ad-401e-b9f7-5cb269127750
Use it
Look up 81802-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81802-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81802-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.